Global Influenza Therapeutics Market Growth (Status and Outlook) 2025-2031
According to this study, the global Influenza Therapeutics market size will reach US$ 10240 million by 2031.
Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Influenza Therapeutics Industry Forecast” looks at past sales and reviews total world Influenza Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Influenza Therapeutics sales for 2025 through 2031. With Influenza Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Influenza Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Influenza Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Influenza Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Influenza Therapeutics Industry Forecast” looks at past sales and reviews total world Influenza Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Influenza Therapeutics sales for 2025 through 2031. With Influenza Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Influenza Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Influenza Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Influenza Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Vaccines
- Drugs
- Hospitals
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- Astrazeneca PLC
- Biocryst Pharmaceuticals, Inc.
- Chiron Corporation
- CSL Limited
- Daiichi Sankyo Co., Ltd.
- Glaxosmithkline PLC
- Mitsubishi Tanabe Pharma Corporation
- Nanotherapeutics Inc.
- Protein Sciences Corporation
- Roche Holding AG
- Sanofi SA
- Shionogi & Co., Ltd.
- Sinovac Biotech Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Therapeutics Market Size (2020-2031)
2.1.2 Influenza Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Influenza Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Influenza Therapeutics Segment by Type
2.2.1 Vaccines
2.2.2 Drugs
2.3 Influenza Therapeutics Market Size by Type
2.3.1 Influenza Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Influenza Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Influenza Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinic
2.4.3 Others
2.5 Influenza Therapeutics Market Size by Application
2.5.1 Influenza Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Influenza Therapeutics Market Size Market Share by Application (2020-2025)
3 INFLUENZA THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Influenza Therapeutics Market Size Market Share by Player
3.1.1 Global Influenza Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Influenza Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Influenza Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFLUENZA THERAPEUTICS BY REGION
4.1 Influenza Therapeutics Market Size by Region (2020-2025)
4.2 Global Influenza Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Influenza Therapeutics Market Size Growth (2020-2025)
4.4 APAC Influenza Therapeutics Market Size Growth (2020-2025)
4.5 Europe Influenza Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Influenza Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Influenza Therapeutics Market Size by Country (2020-2025)
5.2 Americas Influenza Therapeutics Market Size by Type (2020-2025)
5.3 Americas Influenza Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Therapeutics Market Size by Region (2020-2025)
6.2 APAC Influenza Therapeutics Market Size by Type (2020-2025)
6.3 APAC Influenza Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Influenza Therapeutics Market Size by Country (2020-2025)
7.2 Europe Influenza Therapeutics Market Size by Type (2020-2025)
7.3 Europe Influenza Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Influenza Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Influenza Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFLUENZA THERAPEUTICS MARKET FORECAST
10.1 Global Influenza Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Influenza Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Influenza Therapeutics Forecast
10.1.3 APAC Influenza Therapeutics Forecast
10.1.4 Europe Influenza Therapeutics Forecast
10.1.5 Middle East & Africa Influenza Therapeutics Forecast
10.2 Americas Influenza Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Influenza Therapeutics Forecast
10.2.2 Canada Market Influenza Therapeutics Forecast
10.2.3 Mexico Market Influenza Therapeutics Forecast
10.2.4 Brazil Market Influenza Therapeutics Forecast
10.3 APAC Influenza Therapeutics Forecast by Region (2026-2031)
10.3.1 China Influenza Therapeutics Market Forecast
10.3.2 Japan Market Influenza Therapeutics Forecast
10.3.3 Korea Market Influenza Therapeutics Forecast
10.3.4 Southeast Asia Market Influenza Therapeutics Forecast
10.3.5 India Market Influenza Therapeutics Forecast
10.3.6 Australia Market Influenza Therapeutics Forecast
10.4 Europe Influenza Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Influenza Therapeutics Forecast
10.4.2 France Market Influenza Therapeutics Forecast
10.4.3 UK Market Influenza Therapeutics Forecast
10.4.4 Italy Market Influenza Therapeutics Forecast
10.4.5 Russia Market Influenza Therapeutics Forecast
10.5 Middle East & Africa Influenza Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Influenza Therapeutics Forecast
10.5.2 South Africa Market Influenza Therapeutics Forecast
10.5.3 Israel Market Influenza Therapeutics Forecast
10.5.4 Turkey Market Influenza Therapeutics Forecast
10.6 Global Influenza Therapeutics Forecast by Type (2026-2031)
10.7 Global Influenza Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Influenza Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Influenza Therapeutics Product Offered
11.1.3 Abbott Laboratories Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Astrazeneca PLC
11.2.1 Astrazeneca PLC Company Information
11.2.2 Astrazeneca PLC Influenza Therapeutics Product Offered
11.2.3 Astrazeneca PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Astrazeneca PLC Main Business Overview
11.2.5 Astrazeneca PLC Latest Developments
11.3 Biocryst Pharmaceuticals, Inc.
11.3.1 Biocryst Pharmaceuticals, Inc. Company Information
11.3.2 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Offered
11.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Biocryst Pharmaceuticals, Inc. Main Business Overview
11.3.5 Biocryst Pharmaceuticals, Inc. Latest Developments
11.4 Chiron Corporation
11.4.1 Chiron Corporation Company Information
11.4.2 Chiron Corporation Influenza Therapeutics Product Offered
11.4.3 Chiron Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Chiron Corporation Main Business Overview
11.4.5 Chiron Corporation Latest Developments
11.5 CSL Limited
11.5.1 CSL Limited Company Information
11.5.2 CSL Limited Influenza Therapeutics Product Offered
11.5.3 CSL Limited Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 CSL Limited Main Business Overview
11.5.5 CSL Limited Latest Developments
11.6 Daiichi Sankyo Co., Ltd.
11.6.1 Daiichi Sankyo Co., Ltd. Company Information
11.6.2 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Offered
11.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Daiichi Sankyo Co., Ltd. Main Business Overview
11.6.5 Daiichi Sankyo Co., Ltd. Latest Developments
11.7 Glaxosmithkline PLC
11.7.1 Glaxosmithkline PLC Company Information
11.7.2 Glaxosmithkline PLC Influenza Therapeutics Product Offered
11.7.3 Glaxosmithkline PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Glaxosmithkline PLC Main Business Overview
11.7.5 Glaxosmithkline PLC Latest Developments
11.8 Mitsubishi Tanabe Pharma Corporation
11.8.1 Mitsubishi Tanabe Pharma Corporation Company Information
11.8.2 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Offered
11.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Mitsubishi Tanabe Pharma Corporation Main Business Overview
11.8.5 Mitsubishi Tanabe Pharma Corporation Latest Developments
11.9 Nanotherapeutics Inc.
11.9.1 Nanotherapeutics Inc. Company Information
11.9.2 Nanotherapeutics Inc. Influenza Therapeutics Product Offered
11.9.3 Nanotherapeutics Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Nanotherapeutics Inc. Main Business Overview
11.9.5 Nanotherapeutics Inc. Latest Developments
11.10 Protein Sciences Corporation
11.10.1 Protein Sciences Corporation Company Information
11.10.2 Protein Sciences Corporation Influenza Therapeutics Product Offered
11.10.3 Protein Sciences Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Protein Sciences Corporation Main Business Overview
11.10.5 Protein Sciences Corporation Latest Developments
11.11 Roche Holding AG
11.11.1 Roche Holding AG Company Information
11.11.2 Roche Holding AG Influenza Therapeutics Product Offered
11.11.3 Roche Holding AG Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Roche Holding AG Main Business Overview
11.11.5 Roche Holding AG Latest Developments
11.12 Sanofi SA
11.12.1 Sanofi SA Company Information
11.12.2 Sanofi SA Influenza Therapeutics Product Offered
11.12.3 Sanofi SA Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Sanofi SA Main Business Overview
11.12.5 Sanofi SA Latest Developments
11.13 Shionogi & Co., Ltd.
11.13.1 Shionogi & Co., Ltd. Company Information
11.13.2 Shionogi & Co., Ltd. Influenza Therapeutics Product Offered
11.13.3 Shionogi & Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Shionogi & Co., Ltd. Main Business Overview
11.13.5 Shionogi & Co., Ltd. Latest Developments
11.14 Sinovac Biotech Ltd.
11.14.1 Sinovac Biotech Ltd. Company Information
11.14.2 Sinovac Biotech Ltd. Influenza Therapeutics Product Offered
11.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Sinovac Biotech Ltd. Main Business Overview
11.14.5 Sinovac Biotech Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Therapeutics Market Size (2020-2031)
2.1.2 Influenza Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Influenza Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Influenza Therapeutics Segment by Type
2.2.1 Vaccines
2.2.2 Drugs
2.3 Influenza Therapeutics Market Size by Type
2.3.1 Influenza Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Influenza Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Influenza Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinic
2.4.3 Others
2.5 Influenza Therapeutics Market Size by Application
2.5.1 Influenza Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Influenza Therapeutics Market Size Market Share by Application (2020-2025)
3 INFLUENZA THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Influenza Therapeutics Market Size Market Share by Player
3.1.1 Global Influenza Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Influenza Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Influenza Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFLUENZA THERAPEUTICS BY REGION
4.1 Influenza Therapeutics Market Size by Region (2020-2025)
4.2 Global Influenza Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Influenza Therapeutics Market Size Growth (2020-2025)
4.4 APAC Influenza Therapeutics Market Size Growth (2020-2025)
4.5 Europe Influenza Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Influenza Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Influenza Therapeutics Market Size by Country (2020-2025)
5.2 Americas Influenza Therapeutics Market Size by Type (2020-2025)
5.3 Americas Influenza Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Therapeutics Market Size by Region (2020-2025)
6.2 APAC Influenza Therapeutics Market Size by Type (2020-2025)
6.3 APAC Influenza Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Influenza Therapeutics Market Size by Country (2020-2025)
7.2 Europe Influenza Therapeutics Market Size by Type (2020-2025)
7.3 Europe Influenza Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Influenza Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Influenza Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFLUENZA THERAPEUTICS MARKET FORECAST
10.1 Global Influenza Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Influenza Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Influenza Therapeutics Forecast
10.1.3 APAC Influenza Therapeutics Forecast
10.1.4 Europe Influenza Therapeutics Forecast
10.1.5 Middle East & Africa Influenza Therapeutics Forecast
10.2 Americas Influenza Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Influenza Therapeutics Forecast
10.2.2 Canada Market Influenza Therapeutics Forecast
10.2.3 Mexico Market Influenza Therapeutics Forecast
10.2.4 Brazil Market Influenza Therapeutics Forecast
10.3 APAC Influenza Therapeutics Forecast by Region (2026-2031)
10.3.1 China Influenza Therapeutics Market Forecast
10.3.2 Japan Market Influenza Therapeutics Forecast
10.3.3 Korea Market Influenza Therapeutics Forecast
10.3.4 Southeast Asia Market Influenza Therapeutics Forecast
10.3.5 India Market Influenza Therapeutics Forecast
10.3.6 Australia Market Influenza Therapeutics Forecast
10.4 Europe Influenza Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Influenza Therapeutics Forecast
10.4.2 France Market Influenza Therapeutics Forecast
10.4.3 UK Market Influenza Therapeutics Forecast
10.4.4 Italy Market Influenza Therapeutics Forecast
10.4.5 Russia Market Influenza Therapeutics Forecast
10.5 Middle East & Africa Influenza Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Influenza Therapeutics Forecast
10.5.2 South Africa Market Influenza Therapeutics Forecast
10.5.3 Israel Market Influenza Therapeutics Forecast
10.5.4 Turkey Market Influenza Therapeutics Forecast
10.6 Global Influenza Therapeutics Forecast by Type (2026-2031)
10.7 Global Influenza Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Influenza Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Influenza Therapeutics Product Offered
11.1.3 Abbott Laboratories Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Astrazeneca PLC
11.2.1 Astrazeneca PLC Company Information
11.2.2 Astrazeneca PLC Influenza Therapeutics Product Offered
11.2.3 Astrazeneca PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Astrazeneca PLC Main Business Overview
11.2.5 Astrazeneca PLC Latest Developments
11.3 Biocryst Pharmaceuticals, Inc.
11.3.1 Biocryst Pharmaceuticals, Inc. Company Information
11.3.2 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Offered
11.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Biocryst Pharmaceuticals, Inc. Main Business Overview
11.3.5 Biocryst Pharmaceuticals, Inc. Latest Developments
11.4 Chiron Corporation
11.4.1 Chiron Corporation Company Information
11.4.2 Chiron Corporation Influenza Therapeutics Product Offered
11.4.3 Chiron Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Chiron Corporation Main Business Overview
11.4.5 Chiron Corporation Latest Developments
11.5 CSL Limited
11.5.1 CSL Limited Company Information
11.5.2 CSL Limited Influenza Therapeutics Product Offered
11.5.3 CSL Limited Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 CSL Limited Main Business Overview
11.5.5 CSL Limited Latest Developments
11.6 Daiichi Sankyo Co., Ltd.
11.6.1 Daiichi Sankyo Co., Ltd. Company Information
11.6.2 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Offered
11.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Daiichi Sankyo Co., Ltd. Main Business Overview
11.6.5 Daiichi Sankyo Co., Ltd. Latest Developments
11.7 Glaxosmithkline PLC
11.7.1 Glaxosmithkline PLC Company Information
11.7.2 Glaxosmithkline PLC Influenza Therapeutics Product Offered
11.7.3 Glaxosmithkline PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Glaxosmithkline PLC Main Business Overview
11.7.5 Glaxosmithkline PLC Latest Developments
11.8 Mitsubishi Tanabe Pharma Corporation
11.8.1 Mitsubishi Tanabe Pharma Corporation Company Information
11.8.2 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Offered
11.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Mitsubishi Tanabe Pharma Corporation Main Business Overview
11.8.5 Mitsubishi Tanabe Pharma Corporation Latest Developments
11.9 Nanotherapeutics Inc.
11.9.1 Nanotherapeutics Inc. Company Information
11.9.2 Nanotherapeutics Inc. Influenza Therapeutics Product Offered
11.9.3 Nanotherapeutics Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Nanotherapeutics Inc. Main Business Overview
11.9.5 Nanotherapeutics Inc. Latest Developments
11.10 Protein Sciences Corporation
11.10.1 Protein Sciences Corporation Company Information
11.10.2 Protein Sciences Corporation Influenza Therapeutics Product Offered
11.10.3 Protein Sciences Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Protein Sciences Corporation Main Business Overview
11.10.5 Protein Sciences Corporation Latest Developments
11.11 Roche Holding AG
11.11.1 Roche Holding AG Company Information
11.11.2 Roche Holding AG Influenza Therapeutics Product Offered
11.11.3 Roche Holding AG Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Roche Holding AG Main Business Overview
11.11.5 Roche Holding AG Latest Developments
11.12 Sanofi SA
11.12.1 Sanofi SA Company Information
11.12.2 Sanofi SA Influenza Therapeutics Product Offered
11.12.3 Sanofi SA Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Sanofi SA Main Business Overview
11.12.5 Sanofi SA Latest Developments
11.13 Shionogi & Co., Ltd.
11.13.1 Shionogi & Co., Ltd. Company Information
11.13.2 Shionogi & Co., Ltd. Influenza Therapeutics Product Offered
11.13.3 Shionogi & Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Shionogi & Co., Ltd. Main Business Overview
11.13.5 Shionogi & Co., Ltd. Latest Developments
11.14 Sinovac Biotech Ltd.
11.14.1 Sinovac Biotech Ltd. Company Information
11.14.2 Sinovac Biotech Ltd. Influenza Therapeutics Product Offered
11.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Sinovac Biotech Ltd. Main Business Overview
11.14.5 Sinovac Biotech Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Influenza Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Influenza Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Vaccines
Table 4. Major Players of Drugs
Table 5. Influenza Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Influenza Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Influenza Therapeutics Market Size Market Share by Type (2020-2025)
Table 8. Influenza Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Influenza Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Influenza Therapeutics Market Size Market Share by Application (2020-2025)
Table 11. Global Influenza Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Influenza Therapeutics Revenue Market Share by Player (2020-2025)
Table 13. Influenza Therapeutics Key Players Head office and Products Offered
Table 14. Influenza Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Influenza Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Influenza Therapeutics Market Size Market Share by Region (2020-2025)
Table 19. Global Influenza Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Influenza Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Influenza Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Influenza Therapeutics Market Size Market Share by Country (2020-2025)
Table 23. Americas Influenza Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Influenza Therapeutics Market Size Market Share by Type (2020-2025)
Table 25. Americas Influenza Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Influenza Therapeutics Market Size Market Share by Application (2020-2025)
Table 27. APAC Influenza Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Influenza Therapeutics Market Size Market Share by Region (2020-2025)
Table 29. APAC Influenza Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Influenza Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Influenza Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Influenza Therapeutics Market Size Market Share by Country (2020-2025)
Table 33. Europe Influenza Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Influenza Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Influenza Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Influenza Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Influenza Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Influenza Therapeutics
Table 39. Key Market Challenges & Risks of Influenza Therapeutics
Table 40. Key Industry Trends of Influenza Therapeutics
Table 41. Global Influenza Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Influenza Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Influenza Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Influenza Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Abbott Laboratories Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 46. Abbott Laboratories Influenza Therapeutics Product Offered
Table 47. Abbott Laboratories Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Abbott Laboratories Main Business
Table 49. Abbott Laboratories Latest Developments
Table 50. Astrazeneca PLC Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 51. Astrazeneca PLC Influenza Therapeutics Product Offered
Table 52. Astrazeneca PLC Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Astrazeneca PLC Main Business
Table 54. Astrazeneca PLC Latest Developments
Table 55. Biocryst Pharmaceuticals, Inc. Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 56. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Offered
Table 57. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Biocryst Pharmaceuticals, Inc. Main Business
Table 59. Biocryst Pharmaceuticals, Inc. Latest Developments
Table 60. Chiron Corporation Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 61. Chiron Corporation Influenza Therapeutics Product Offered
Table 62. Chiron Corporation Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Chiron Corporation Main Business
Table 64. Chiron Corporation Latest Developments
Table 65. CSL Limited Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 66. CSL Limited Influenza Therapeutics Product Offered
Table 67. CSL Limited Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. CSL Limited Main Business
Table 69. CSL Limited Latest Developments
Table 70. Daiichi Sankyo Co., Ltd. Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 71. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Offered
Table 72. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Daiichi Sankyo Co., Ltd. Main Business
Table 74. Daiichi Sankyo Co., Ltd. Latest Developments
Table 75. Glaxosmithkline PLC Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 76. Glaxosmithkline PLC Influenza Therapeutics Product Offered
Table 77. Glaxosmithkline PLC Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Glaxosmithkline PLC Main Business
Table 79. Glaxosmithkline PLC Latest Developments
Table 80. Mitsubishi Tanabe Pharma Corporation Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 81. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Offered
Table 82. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Mitsubishi Tanabe Pharma Corporation Main Business
Table 84. Mitsubishi Tanabe Pharma Corporation Latest Developments
Table 85. Nanotherapeutics Inc. Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 86. Nanotherapeutics Inc. Influenza Therapeutics Product Offered
Table 87. Nanotherapeutics Inc. Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Nanotherapeutics Inc. Main Business
Table 89. Nanotherapeutics Inc. Latest Developments
Table 90. Protein Sciences Corporation Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 91. Protein Sciences Corporation Influenza Therapeutics Product Offered
Table 92. Protein Sciences Corporation Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Protein Sciences Corporation Main Business
Table 94. Protein Sciences Corporation Latest Developments
Table 95. Roche Holding AG Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 96. Roche Holding AG Influenza Therapeutics Product Offered
Table 97. Roche Holding AG Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Roche Holding AG Main Business
Table 99. Roche Holding AG Latest Developments
Table 100. Sanofi SA Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 101. Sanofi SA Influenza Therapeutics Product Offered
Table 102. Sanofi SA Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Sanofi SA Main Business
Table 104. Sanofi SA Latest Developments
Table 105. Shionogi & Co., Ltd. Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 106. Shionogi & Co., Ltd. Influenza Therapeutics Product Offered
Table 107. Shionogi & Co., Ltd. Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Shionogi & Co., Ltd. Main Business
Table 109. Shionogi & Co., Ltd. Latest Developments
Table 110. Sinovac Biotech Ltd. Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 111. Sinovac Biotech Ltd. Influenza Therapeutics Product Offered
Table 112. Sinovac Biotech Ltd. Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Sinovac Biotech Ltd. Main Business
Table 114. Sinovac Biotech Ltd. Latest Developments
Table 1. Influenza Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Influenza Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Vaccines
Table 4. Major Players of Drugs
Table 5. Influenza Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Influenza Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Influenza Therapeutics Market Size Market Share by Type (2020-2025)
Table 8. Influenza Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Influenza Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Influenza Therapeutics Market Size Market Share by Application (2020-2025)
Table 11. Global Influenza Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Influenza Therapeutics Revenue Market Share by Player (2020-2025)
Table 13. Influenza Therapeutics Key Players Head office and Products Offered
Table 14. Influenza Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Influenza Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Influenza Therapeutics Market Size Market Share by Region (2020-2025)
Table 19. Global Influenza Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Influenza Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Influenza Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Influenza Therapeutics Market Size Market Share by Country (2020-2025)
Table 23. Americas Influenza Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Influenza Therapeutics Market Size Market Share by Type (2020-2025)
Table 25. Americas Influenza Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Influenza Therapeutics Market Size Market Share by Application (2020-2025)
Table 27. APAC Influenza Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Influenza Therapeutics Market Size Market Share by Region (2020-2025)
Table 29. APAC Influenza Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Influenza Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Influenza Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Influenza Therapeutics Market Size Market Share by Country (2020-2025)
Table 33. Europe Influenza Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Influenza Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Influenza Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Influenza Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Influenza Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Influenza Therapeutics
Table 39. Key Market Challenges & Risks of Influenza Therapeutics
Table 40. Key Industry Trends of Influenza Therapeutics
Table 41. Global Influenza Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Influenza Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Influenza Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Influenza Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Abbott Laboratories Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 46. Abbott Laboratories Influenza Therapeutics Product Offered
Table 47. Abbott Laboratories Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Abbott Laboratories Main Business
Table 49. Abbott Laboratories Latest Developments
Table 50. Astrazeneca PLC Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 51. Astrazeneca PLC Influenza Therapeutics Product Offered
Table 52. Astrazeneca PLC Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Astrazeneca PLC Main Business
Table 54. Astrazeneca PLC Latest Developments
Table 55. Biocryst Pharmaceuticals, Inc. Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 56. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product Offered
Table 57. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Biocryst Pharmaceuticals, Inc. Main Business
Table 59. Biocryst Pharmaceuticals, Inc. Latest Developments
Table 60. Chiron Corporation Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 61. Chiron Corporation Influenza Therapeutics Product Offered
Table 62. Chiron Corporation Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Chiron Corporation Main Business
Table 64. Chiron Corporation Latest Developments
Table 65. CSL Limited Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 66. CSL Limited Influenza Therapeutics Product Offered
Table 67. CSL Limited Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. CSL Limited Main Business
Table 69. CSL Limited Latest Developments
Table 70. Daiichi Sankyo Co., Ltd. Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 71. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product Offered
Table 72. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Daiichi Sankyo Co., Ltd. Main Business
Table 74. Daiichi Sankyo Co., Ltd. Latest Developments
Table 75. Glaxosmithkline PLC Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 76. Glaxosmithkline PLC Influenza Therapeutics Product Offered
Table 77. Glaxosmithkline PLC Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Glaxosmithkline PLC Main Business
Table 79. Glaxosmithkline PLC Latest Developments
Table 80. Mitsubishi Tanabe Pharma Corporation Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 81. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product Offered
Table 82. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Mitsubishi Tanabe Pharma Corporation Main Business
Table 84. Mitsubishi Tanabe Pharma Corporation Latest Developments
Table 85. Nanotherapeutics Inc. Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 86. Nanotherapeutics Inc. Influenza Therapeutics Product Offered
Table 87. Nanotherapeutics Inc. Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Nanotherapeutics Inc. Main Business
Table 89. Nanotherapeutics Inc. Latest Developments
Table 90. Protein Sciences Corporation Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 91. Protein Sciences Corporation Influenza Therapeutics Product Offered
Table 92. Protein Sciences Corporation Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Protein Sciences Corporation Main Business
Table 94. Protein Sciences Corporation Latest Developments
Table 95. Roche Holding AG Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 96. Roche Holding AG Influenza Therapeutics Product Offered
Table 97. Roche Holding AG Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Roche Holding AG Main Business
Table 99. Roche Holding AG Latest Developments
Table 100. Sanofi SA Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 101. Sanofi SA Influenza Therapeutics Product Offered
Table 102. Sanofi SA Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Sanofi SA Main Business
Table 104. Sanofi SA Latest Developments
Table 105. Shionogi & Co., Ltd. Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 106. Shionogi & Co., Ltd. Influenza Therapeutics Product Offered
Table 107. Shionogi & Co., Ltd. Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Shionogi & Co., Ltd. Main Business
Table 109. Shionogi & Co., Ltd. Latest Developments
Table 110. Sinovac Biotech Ltd. Details, Company Type, Influenza Therapeutics Area Served and Its Competitors
Table 111. Sinovac Biotech Ltd. Influenza Therapeutics Product Offered
Table 112. Sinovac Biotech Ltd. Influenza Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Sinovac Biotech Ltd. Main Business
Table 114. Sinovac Biotech Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Influenza Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Influenza Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Influenza Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Influenza Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Influenza Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Influenza Therapeutics Market Size Market Share by Type in 2024
Figure 10. Influenza Therapeutics in Hospitals
Figure 11. Global Influenza Therapeutics Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Influenza Therapeutics in Clinic
Figure 13. Global Influenza Therapeutics Market: Clinic (2020-2025) & ($ millions)
Figure 14. Influenza Therapeutics in Others
Figure 15. Global Influenza Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Influenza Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Influenza Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Influenza Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Influenza Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Influenza Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Influenza Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Influenza Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Influenza Therapeutics Value Market Share by Country in 2024
Figure 24. United States Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Influenza Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Influenza Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Influenza Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Influenza Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Influenza Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Influenza Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Influenza Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Influenza Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Influenza Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Influenza Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Influenza Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 1. Influenza Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Influenza Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Influenza Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Influenza Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Influenza Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Influenza Therapeutics Market Size Market Share by Type in 2024
Figure 10. Influenza Therapeutics in Hospitals
Figure 11. Global Influenza Therapeutics Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Influenza Therapeutics in Clinic
Figure 13. Global Influenza Therapeutics Market: Clinic (2020-2025) & ($ millions)
Figure 14. Influenza Therapeutics in Others
Figure 15. Global Influenza Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 16. Global Influenza Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Influenza Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Influenza Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Influenza Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Influenza Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Influenza Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Influenza Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Influenza Therapeutics Value Market Share by Country in 2024
Figure 24. United States Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Influenza Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Influenza Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Influenza Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Influenza Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Influenza Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Influenza Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Influenza Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Influenza Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Influenza Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Influenza Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Influenza Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Influenza Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Influenza Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Influenza Therapeutics Market Size 2026-2031 ($ millions)
More Publications
Global Chimeric Antigen Receptor Cell Therapy Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
176 pages
Global Gleptoferron (Iron-Dextran Heptonic Acid Complex) Market Growth 2025-2031
US$ 3,660.00
December 2025
85 pages
Global Myasthenia Gravis Therapies Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
79 pages
